For citations:
Shamkhalova M.S., Sukhareva O.Yu., Yevloyeva M.I. FIDELIO study: significance and place of finerenone as nonsteroidal mineralocorticoid receptor antagonist in therapy of patients with chronic kidney disease in type 2 diabetes. Diabetes mellitus. 2023;26(6):603-614. (In Russ.) https://doi.org/10.14341/DM13107

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).